Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in noncirrhotic chronic hepatitis B patients-Reference-Cited by-同舟云学术

Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in noncirrhotic chronic hepatitis B patients

Published:2018-09 Issue:9 Volume:24 Page:997-1003
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Chen C.-H.,Hung C.-H.,Wang J.-H.,Lu S.-N.,Hu T.-H.,Lee C.-M.

Funder

National Science Council, Taiwan

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference28 articles.

1. A comparison of four-year entecavir efficacy in nucleos(t)ide analogue-naïve and -experienced adult Taiwanese chronic hepatitis B patients;Chen;Hepatol Int,2013

2. Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients;Ono;J Hepatol,2012

3. Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea;Song;Hepatology,2000

4. Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation;Lee;J Hepatol,2002

5. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update;Liaw;Hepatol Int,2012

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High end‐of‐treatment hepatitis B core‐related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy;Liver International;2024-07-15

2. Long-term hepatitis B surface antigen kinetics after nucleos(t)ide analog discontinuation in patients with noncirrhotic chronic hepatitis B;Liver Research;2024-07

3. Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy;Virology Journal;2024-04-03

4. Sustained response and HBsAg loss after nucleo(s)tide analogue discontinuation in chronic hepatitis B patients: the prospective SNAP study;Clinics and Research in Hepatology and Gastroenterology;2024-02

5. Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply;Alimentary Pharmacology & Therapeutics;2023-12-12